reference/4735928

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4735928

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	19
issn	0578-1310
issueIdentifier	1
pageRange	14-19
publicationName	Zhonghua er ke za zhi = Chinese journal of pediatrics
startingPage	14
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_92f37fe33a645cd63e8548c6cb8aae43 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_df045dc23d4232c3777b7224f6a14732 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_49413465d00a378412bdbc6217f2c6eb
bibliographicCitation	Xie LP, Zhao L, Chu C, He L, Liang XC, Sun SN, Zhao QM, Wang F, Cao YY, Lin YX, Zeng ZQ, Wu L, Huang GY, Liu F. [Retrospective analysis of infliximab in the treatment of Kawasaki disease]. Zhonghua Er Ke Za Zhi. 2022 Jan 02;60(1):14–9. doi: 10.3760/cma.j.cn112140-20210713-00576. PMID: 34986617.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ca8ac8c6f570fd639a8397f1986739a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_963cf663cb0028a682bce2fadb939e3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1100826356ddce09cfc57ec2b73f9719 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83003a06ecddcb00b42750df93639170 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1151b405254df4bcbc6aabb7135527f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e52e24bc50bc7872782af477164116ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c675c8b59f797994788f237f77dd0f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faad4ddc3f81d966c720667571431120 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5f26bed0fe60c29b8e4beb92b05ca12 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_742d45fb20f8d0eefa4a22b3b0031288 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3758575da0d76470a0817d103728a5aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bcd6b1d53ad3e5237091ea5516a9592 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7813da38cfd781a30535b03020a6e93b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6770fb643f18940e0712b24c0591d8da
date	2022-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3760/cma.j.cn112140-20210713-00576 https://pubmed.ncbi.nlm.nih.gov/34986617
isPartOf	https://portal.issn.org/resource/ISSN/0578-1310 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30260
language	Chinese
source	https://pubmed.ncbi.nlm.nih.gov/
title	[Retrospective analysis of infliximab in the treatment of Kawasaki disease]
discusses	http://id.nlm.nih.gov/mesh/M0025515 http://id.nlm.nih.gov/mesh/M0282056
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009080Q000188 http://id.nlm.nih.gov/mesh/D003323Q000188 http://id.nlm.nih.gov/mesh/D003323Q000209
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D016756Q000627 http://id.nlm.nih.gov/mesh/D000069285Q000009 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6892 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9136 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8522 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7345 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6965

Total number of triples: 56.